Susquehanna International Group, LLP Cellectis S.A. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$8.01 - $12.84 $41,652 - $66,768	-5,200 Reduced 24.41%	16,100 $131,000
Q3 2021 Nov 15, 2021	BUY	$11.94 - $16.09 $81,192 - $109,412	6,800 Added 46.9%	21,300 $269,000
Q2 2021 Aug 11, 2021	SELL	$14.36 - $20.93 $473,880 - $690,690	-33,000 Reduced 69.47%	14,500 $224,000
Q1 2021 May 17, 2021	SELL	$18.19 - $33.25 $232,832 - $425,600	-12,800 Reduced 21.23%	47,500 $960,000
Q4 2020 Feb 16, 2021	BUY	$15.87 - $31.64 $636,387 - $1.27 Million	40,100 Added 198.51%	60,300 $1.63 Million
Q3 2020 Nov 16, 2020	BUY	$15.7 - $20.84 $317,140 - $420,968	20,200 New	20,200 $374,000
Q2 2020 Aug 14, 2020	SELL	$8.21 - $21.02 $211,818 - $542,316	-25,800 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.81 - $18.82 $49,984 - $120,448	6,400 Added 32.99%	25,800 $237,000
Q4 2019 Feb 14, 2020	BUY	$9.73 - $19.31 $188,762 - $374,614	19,400 New	19,400 $332,000
Q3 2019 Nov 14, 2019	SELL	$10.15 - $16.89 $398,895 - $663,777	-39,300 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$14.6 - $20.6 $189,800 - $267,800	-13,000 Reduced 24.86%	39,300 $613,000
Q1 2019 May 15, 2019	BUY	$15.53 - $19.75 $177,042 - $225,150	11,400 Added 27.87%	52,300 $959,000
Q4 2018 Feb 14, 2019	SELL	$15.58 - $28.41 $462,726 - $843,777	-29,700 Reduced 42.07%	40,900 $681,000
Q3 2018 Nov 14, 2018	BUY	$25.99 - $30.6 $1.37 Million - $1.62 Million	52,900 Added 298.87%	70,600 $1.99 Million
Q2 2018 Aug 14, 2018	BUY	$27.78 - $38.53 $5,556 - $7,706	200 Added 1.14%	17,700 $501,000
Q1 2018 May 15, 2018	SELL	$27.78 - $35.19 $433,368 - $548,964	-15,600 Reduced 47.13%	17,500 $551,000
Q4 2017 Feb 14, 2018	SELL	$23.33 - $35.01 $478,264 - $717,705	-20,500 Reduced 38.25%	33,100 $965,000
Q3 2017 Nov 14, 2017	BUY	$21.65 - $32.18 $1.16 Million - $1.72 Million	53,600	53,600 $1.53 Million

Others Institutions Holding CLLS

# of Institutions

Shares Held

11.2M

Call Options Held

2.8K

Put Options Held

17.9K

Long Focus Capital Management, LLC San Juan, PR

4.62M
Shares

$9.14 Million
0.35% of portfolio
Capital International Investors Los Angeles, CA

1.85M
Shares

$3.66 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.44M
Shares

$2.85 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

1.44M
Shares

$2.85 Million
0.0% of portfolio
Baillie Gifford & CO

708K
Shares

$1.4 Million
0.0% of portfolio

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $90.1M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account